5.60
price down icon4.11%   -0.24
after-market Handel nachbörslich: 5.59 -0.010 -0.18%
loading

Verastem Inc Aktie (VSTM) Neueste Nachrichten

pulisher
Mar 12, 2026

Verastem (VSTM) Q4 2025 Earnings Call Transcript - AOL.com

Mar 12, 2026
pulisher
Mar 12, 2026

Verastem's (VSTM) Buy Rating Reaffirmed at BTIG Research - MarketBeat

Mar 12, 2026
pulisher
Mar 11, 2026

Verastem stock initiated at Buy by BTIG with $19 price target - Investing.com

Mar 11, 2026
pulisher
Mar 11, 2026

Wall Street Analysts See a 159.31% Upside in Verastem (VSTM): Can the Stock Really Move This High? - Yahoo Finance

Mar 11, 2026
pulisher
Mar 10, 2026

Jefferies Financial Group Inc. Increases Stake in Verastem, Inc. $VSTM - MarketBeat

Mar 10, 2026
pulisher
Mar 09, 2026

Earnings call transcript: Verastem’s Q4 2025 results highlight oncology growth - Investing.com Nigeria

Mar 09, 2026
pulisher
Mar 09, 2026

Verastem Earnings Call: Early Momentum, Long Runway Risks - TipRanks

Mar 09, 2026
pulisher
Mar 07, 2026

Verastem (NASDAQ:VSTM) Raised to Hold at Wall Street Zen - MarketBeat

Mar 07, 2026
pulisher
Mar 06, 2026

Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 06, 2026
pulisher
Mar 06, 2026

Jefferies Maintains Buy on Verastem, Inc. (VSTM) March 2026 - Meyka

Mar 06, 2026
pulisher
Mar 05, 2026

Verastem (VSTM) Q4 Revenue Debut Highlights Ongoing Losses And Tests Bullish Profitability Timeline - simplywall.st

Mar 05, 2026
pulisher
Mar 05, 2026

Verastem 2025 Financial Results: Q4 and Annual Revenue & LossNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform

Mar 05, 2026
pulisher
Mar 05, 2026

Why Did Verastem Stock Jump After-Hours Despite An Earnings Miss? - Stocktwits

Mar 05, 2026
pulisher
Mar 05, 2026

Jefferies reiterates Verastem stock rating on launch progress By Investing.com - Investing.com Canada

Mar 05, 2026
pulisher
Mar 05, 2026

Verastem, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 05, 2026
pulisher
Mar 05, 2026

Verastem, Inc. (NASDAQ:VSTM) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Verastem Inc (VSTM) Q4 2025 Earnings Call Highlights: Transition to Commercial Stage and Financial Challenges - GuruFocus

Mar 05, 2026
pulisher
Mar 04, 2026

Verastem Q4 2025 Earnings Call Transcript - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem Q4 Earnings Call Highlights - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem: Fourth Quarter Financial Results Overview - Bitget

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem (VSTM) Reports Strong Q4 2025 Earnings and Progress in Clinical Trials - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

Key Developments for Verastem (VSTM) in 2026 Clinical Trials - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem Highlights AVMAPKI FAKZYNJA Strategy and Pipeline Risks - TipRanks

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem (VSTM) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem (VSTM) Reports Strong Revenue and Advances Cancer Treat - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem (NASDAQ:VSTM) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem: Q4 Earnings Snapshot - KVUE

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem, Inc. releases Q4 and year end 2025 results with business update - Traders Union

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem (VSTM) shares updated March 4, 2026 corporate presentation - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Earnings Summary: Verastem Q4 - Benzinga

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem (NASDAQ: VSTM) grows LGSOC launch and advances KRAS G12D programs - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Business Updates - Business Wire

Mar 04, 2026
pulisher
Mar 04, 2026

Verastem Inc (VSTM) Q4 2025 Earnings Call Highlights: Transition to Commercial Stage and ... By GuruFocus - Investing.com Canada

Mar 04, 2026
pulisher
Mar 03, 2026

Earnings Outlook For Verastem - Benzinga

Mar 03, 2026
pulisher
Mar 01, 2026

VSTM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 01, 2026
pulisher
Feb 27, 2026

Verastem (VSTM): Can This Beaten-Down Biotech Still Surprise Wall Street? - AD HOC NEWS

Feb 27, 2026
pulisher
Feb 25, 2026

Will Avmapki Fakzynja Co-Pack Drive Sustainable Growth For Verastem This Year? - RTTNews

Feb 25, 2026
pulisher
Feb 25, 2026

Verastem (VSTM) Projected to Post Earnings on Wednesday - MarketBeat

Feb 25, 2026
pulisher
Feb 23, 2026

VSTM Technical Analysis & ETF Price Forecast - Intellectia AI

Feb 23, 2026
pulisher
Feb 21, 2026

Balyasny Asset Management L.P. Increases Stake in Verastem Inc. - GuruFocus

Feb 21, 2026
pulisher
Feb 20, 2026

Verastem, Inc. (VSTM) Stock Analysis: Navigating the 179% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Feb 20, 2026
pulisher
Feb 18, 2026

Verastem Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - Business Wire

Feb 18, 2026
pulisher
Feb 17, 2026

What Makes Verastem (VSTM) a New Buy Stock - Yahoo Finance

Feb 17, 2026
pulisher
Feb 17, 2026

RTW holds 7.84M Verastem (VSTM) shares with ownership capped at 9.99% - Stock Titan

Feb 17, 2026
pulisher
Feb 16, 2026

Verastem Touts 50%+ Sales Growth for LGSOC Launch, Teases RAMP 301 and KRAS G12D Catalysts - MarketBeat

Feb 16, 2026
pulisher
Feb 13, 2026

Verastem, Inc. (VSTM) Investor Outlook: Unveiling A Potential 184.67% Upside In Biotech - DirectorsTalk Interviews

Feb 13, 2026
pulisher
Feb 12, 2026

Gap Down: What analysts say about Verastem Inc stock2025 Historical Comparison & Stock Timing and Entry Methods - baoquankhu1.vn

Feb 12, 2026
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):